Antiproliferative effect of D-glucuronyl C5-epimerase in human breast cancer cells

Cancer Cell International

Volumn 10, Issue , 2010, Pages

  Prudnikova, Tatiana Y ^a   Mostovich, Liudmila A ^a   Domanitskaya, Natalia V ^a   Pavlova, Tatiana V ^b   Kashuba, Vladimir I ^b,c   Zabarovsky, Eugene R ^b,d   Grigorieva, Elvira V ^a,b  

^a INSTITUTE OF MOLECULAR BIOLOGY AND BIOPHYSICS   (Russian Federation)

^b STOCKHOLM SÖDER HOSPITAL   (Sweden)

^c INSTITUTE OF MOLECULAR BIOLOGY AND GENETICS   (Ukraine)

^d ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTERFERON; BRCA1 PROTEIN; COMPLEMENTARY DNA; DEXTRO GLUCURONYL C5 EPIMERASE; EPIMERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN 1; INTERLEUKIN 8; MESSENGER RNA; PLASMID DNA; PROTEIN BCL 2; PROTEIN KINASE SYK; PROTEIN P53; PROTEIN S 100; PROTEIN S 100 A4; PROTEOHEPARAN SULFATE; TRANSCRIPTION FACTOR E2F1; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CELL CYCLE REGULATION; CELL PROLIFERATION; CELL STRAIN MCF 7; CELL VIABILITY; COLONY FORMATION; CONTROLLED STUDY; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC TRANSFECTION; GLCE GENE; HUMAN; HUMAN CELL; METASTASIS; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 77955673524     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-10-27     Document Type: Article

References (29)

1. Ori A, Wilkinson MC, Fernig DG. The heparanome and regulation of cell function: structures, functions and challenges. Front Biosci 2008, 13:4309-4338. 10.2741/3007, 18508513.
2. Alexopoulou AN, Multhaupt HA, Couchman JR. Syndecans in wound healing, inflammation and vascular biology. Int J Biochem Cell Biol 2007, 39(3):505-528. 10.1016/j.biocel.2006.10.014, 17097330.
3. Filmus J, Capurro M, Rast J. Glypicans. Genome Biol 2008, 9(5):224. 10.1186/gb-2008-9-5-224, 2441458, 18505598.
4. Whitelock JM, Melrose J, Iozzo RV. Diverse cell signaling events modulated by perlecan. Biochemistry 2008, 47(43):11174-11183. 10.1021/bi8013938, 2605657, 18826258.
5. Nadanaka S, Kitagawa H. Heparan sulphate biosynthesis and disease. J Biochem 2008, 144(1):7-14. 10.1093/jb/mvn040, 18367479.
6. Iozzo RV, Zoeller JJ, Nystro{cyrillic}m A. Basement membrane proteoglycans: modulators Par Excellence of cancer growth and angiogenesis. Mol Cells 2009, 27(5):503-513. 10.1007/s10059-009-0069-0, 19466598.
7. Blackhall FH, Merry CL, Davies EJ, Jayson GC. Heparan sulfate proteoglycans and cancer. Br J Cancer 2001, 85(8):1094-1098. 10.1054/bjoc.2001.2054, 2375159, 11710818.
8. Yip GW, Smollich M, Götte M. Therapeutic value of glycosaminoglycans in cancer. Mol Cancer Ther 2006, 5(9):2139-2148. 10.1158/1535-7163.MCT-06-0082, 16985046.
9. Hagner-McWhirter A, Li JP, Oscarson S, Lindahl U. Irreversible glucuronyl C5-epimerization in the biosynthesis of heparan sulfate. J Biol Chem 2004, 279(15):14631-14638. 10.1074/jbc.M313760200, 14718527.
10. Li J, Hagner-McWhirter A, Kjellén L, Palgi J, Jalkanen M, Lindahl U. Biosynthesis of heparin/heparan sulfate. cDNA cloning and expression of D-glucuronyl C5-epimerase from bovine lung. J Biol Chem 1997, 272(44):28158-28163. 10.1074/jbc.272.44.28158, 9346972.
11. Li JP, Gong F, El Darwish K, Jalkanen M, Lindahl U. Characterization of the D-glucuronyl C5-epimerase involved in the biosynthesis of heparin and heparan sulfate. J Biol Chem 2001, 276(23):20069-20077. 10.1074/jbc.M011783200, 11274177.
12. Crawford BE, Olson SK, Esko JD, Pinhal MA. Cloning, Golgi localization, and enzyme activity of the full-length heparin/heparan sulfate-glucuronic acid C5-epimerase. J Biol Chem 2001, 276(24):21538-21543.
13. Li JP, Gong F, Hagner-McWhirter A, Forsberg E, Abrink M, Kisilevsky R, Zhang X, Lindahl U. Targeted disruption of a murine glucuronyl C5-epimerase gene results in heparan sulfate lacking L-iduronic acid and in neonatal lethality. J Biol Chem 2003, 278(31):28363-28366. 10.1074/jbc.C300219200, 12788935.
14. Ghiselli G, Farber SA. D-glucuronyl C5-epimerase acts in dorso-ventral axis formation in zebrafish. BMC Dev Biol 2005, 5:19. 10.1186/1471-213X-5-19, 1250224, 16156897.
15. Ghiselli G, Agrawal A. The human D-glucuronyl C5-epimerase gene is transcriptionally activated through the beta-catenin-TCF4 pathway. Biochem J 2005, 390(Pt 2):493-499. 1198929, 15853773.
16. Jia J, Maccarana M, Zhang X, Bespalov M, Lindahl U, Li JP. Lack of L-iduronic acid in heparan sulfate affects interaction with growth factors and cell signaling. J Biol Chem 2009, 284(23):15942-15950. 10.1074/jbc.M809577200, 2708889, 19336402.
17. Catlow KR, Deakin JA, Wei Z, Delehedde M, Fernig DG, Gherardi E, Gallagher JT, Pavão MS, Lyon M. Interactions of hepatocyte growth factor/scatter factor with various glycosaminoglycans reveal an important interplay between the presence of iduronate and sulfate density. J Biol Chem 2008, 283(9):5235-5248. 10.1074/jbc.M706589200, 18156180.
18. Eshchenko TY, Rykova VI, Chernakov AE, Sidorov SV, Grigorieva EV. Expression of Different Proteoglycans in Human Breast Tumors. Biochemistry (Moscow) 2007, 72:1016-1020.
19. Grigorieva E, Eshchenko T, Rykova VI, Chernakov A, Zabarovsky ER, Sidorov SV. Decreased expression of human D-glycuronyl C5-epimerase in brest cancer. Int. J of Cancer 2008, 122(5):1172-1176.
20. Ropero S, Setien F, Espada J, et al. Epigenetic loss of the familial tumor-suppressor gene exostosin-1 (EXT1) disrupts heparan sulfate synthesis in cancer cells. Hum Mol Genet 2004, 13(22):2753-2765. 10.1093/hmg/ddh298, 15385438.
21. Osterholm C, Barczyk MM, Busse M, Grønning M, Reed RK, Kusche-Gullberg M. Mutation in the heparan sulfate biosynthesis enzyme EXT1 influences growth factor signaling and fibroblast interactions with the extracellular matrix. J Biol Chem 2009, 284(50):34935-34943. 10.1074/jbc.M109.005264, 19850926.
22. Deng CX. BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution. Nucleic Acids Res 2006, 34(5):1416-1426. 10.1093/nar/gkl010, 1390683, 16522651.
23. Sung YM, Xu X, Sun J, Mueller D, Sentissi K, Johnson P, Urbach E, Seillier-Moiseiwitsch F, Johnson MD, Mueller SC. Tumor suppressor function of Syk in human MCF10A in vitro and normal mouse mammary epithelium in vivo. PLoS One 2009, 4(10):e7445. 10.1371/journal.pone.0007445, 2759536, 19829710.
24. Polager S, Ginsberg D. p53 and E2f: partners in life and death. Nat Rev Cancer 2009, 9(10):738-748. 10.1038/nrc2718, 19776743.
25. Thomadaki H, Scorilas A. BCL2 family of apoptosis-related genes: functions and clinical implications in cancer. Crit Rev Clin Lab Sci 2006, 43(1):1-67. 10.1080/10408360500295626, 16531274.
26. Bours V, Bentires-Alj M, Hellin AC, Viatour P, Robe P, Delhalle S, Benoit V, Merville MP. Nuclear factor-kappa B, cancer, and apoptosis. Biochem Pharmacol 2000, 60(8):1085-1089. 10.1016/S0006-2952(00)00391-9, 11007945.
27. Padua D, Massagué J. Roles of TGFbeta in metastasis. Cell Res 2009, 19(1):89-102. 10.1038/cr.2008.316, 19050696.
28. Vaidya KS, Welch DR. Metastasis suppressors and their roles in breast carcinoma. J Mammary Gland Biol Neoplasia 2007, 12(2-3):175-190. 10.1007/s10911-007-9049-1, 1971219, 17587154.
29. Helfman DM, Kim EJ, Lukanidin E, Grigorian M. The metastasis associated protein S100A4: role in tumour progression and metastasis. Br J Cancer 2005, 92(11):1955-1958. 10.1038/sj.bjc.6602613, 2361793, 15900299.